Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lisa Pappas-Taffer
The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-Ctla4 Agents: The Growing Role of the Dermatologist in the Management of Patients With Metastatic Melanoma
Current Dermatology Reports
Dermatology
Related publications
Combining Checkpoint Inhibitors and BRAF-targeted Agents Against Metastatic Melanoma
OncoImmunology
Oncology
Allergy
Immunology
Detection of Mutant BRAF Alleles in the Plasma of Patients With Metastatic Melanoma
Journal of Molecular Diagnostics
Forensic Medicine
Pathology
Molecular Medicine
Pcn220 - End-Of-Life Care in Patients With Metastatic Cutaneous Melanoma in the Netherlands
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Accelerated BRAF Mutation Analysis Using a Fully Automated PCR Platform Improves the Management of Patients With Metastatic Melanoma
Oncotarget
Oncology
CTLA4 Blockade Increases Th17 Cells in Patients With Metastatic Melanoma
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Management of Side-Effects of Selective-Serotonin Re-Uptake Inhibitors
Current Psychopharmacology
Psychiatry
Mental Health
Pharmacology
Revisiting the Role of Bone-Modifying Agents in the Management of Metastatic Prostate Cancer
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-Ctla-4 Therapy in Metastatic Melanoma From the Ipilimumab Network
PLoS ONE
Multidisciplinary
Thrombophilic Status May Predict Prognosis in Patients With Metastatic BRAFV600-mutated Melanoma Who Are Receiving BRAF Inhibitors
Journal of the American Academy of Dermatology
Dermatology
